ELI LILLY: LATEST U.S. PHARMA COMPANY TO HALT COVID-19 DRUG TRIALS

Highlights

• Eli Lilly has decided to suspend Phase 3 of its lab-produced anti-body treatment in hospitalized patients over an unspecified incident

• Previously AstraZeneca-University of Oxford developed coronavirus vaccine trials were put on hold after one of its ca...

JOHNSON & JOHNSON HALTS COVID-19 VACCINE TRIALS AFTER A PARTICIPANT FALLS ILL

Highlights

• Johnson & Johnson in its statement said that the company's clinical and safety physicians along with an independent data and safety monitoring board are reviewing the participant’s illness

• The pharmaceutical giant further said that these ...

ASTRAZENECA HOPEFUL ABOUT RESUMPTION OF U.S. VACCINE TRIALS

Highlights

• Reports state that AstraZeneca is hopeful that the global approval will be determined by results in tests conducted outside the U.S. 

• Human clinical trials in the U.S. were halted by the FDA in early September after a volunteer came down with unex...

THE U.S. WITNESSES DROP IN COVID-19 RELATED DEATHS

• Current Total Cases: 6,339,403

• Total Deaths : 191,191

• Cumulative recoveries : 3,575,866

• Top five states that has the maximum number of cases : 

? California: Cases 726,377,number of deaths 13,496. Active cases 369,018

CLINICAL TRIALS OF A COVID-19 VACCINE HAVE STARTED IN JAPAN; PRODUCT OF ASTRAZENECA

Highlights –

• Clinical trials of a COVID-19 vaccine have started in Japan; product of AstraZeneca.
• AstraZeneca plans to supply vaccines to Japan starting next year.
• The name of the vaccine candidate is AZD1222, developed with the Univ...

UNIVERSITY OF OXFORD & ASTRAZENECA PLC COLLABORATED COVID-19 VACCINE IN 3RD STAGE OF SUCCESSFUL HUMAN TRIAL

Highlights: 

• The first two stages of the vaccine have been successful 
• The UK is one of the many countries desperately trying to develop a stable vaccine against covid19. 

Seven months on with the coronavirus pandemic, it remains a nui...

FURTHER SIX MONTHS FOR SAFE COVID-19 VACCINE SAYS SERUM INSTITUTE OF INDIA

Serum Institute of India (SII), Indian vaccine developer from the city of Pune has stated that it will take at least six months before we see arrival of COVID-19 vaccine that will be safe to use for general public. The need for the vaccine seems extremely urgent as the number of COVID-19 cases in...

DEXAMETHASONE, A LOW-COST ANTI-INFLAMMATORY DRUG IMPROVES COVID – 19 PATIENT’S SURVIVAL

Highlights

• Globally, it will save countless lives
• Dexamethasone benefits severe cases

Dexamethasone, a drug, improved survival in coronavirus patients. It is a low-cost, widely used anti-inflammatory drug. After struggling with the p...

ASTRAZENECA RECIEVES $1 BILLION FROM THE U.S. TO FUND COVID-19 VACCINE

Highlights

• AstraZeneca stated that it was engaging with various international organisations including the World Health Organization (WHO) for fair allocation and distribution of the vaccine globally

• AstraZeneca has partnered with the University of Oxford to devel...